Zacks Investment Research upgraded shares of Xylem (NYSE:XYL) from a hold rating to a buy rating in a research report report published on Saturday morning. Zacks Investment Research currently has $84.00 target price on the industrial products company’s stock.
According to Zacks, “Xylem’s shares have outperformed the industry in three months’ time. The company reported robust fourth-quarter 2017 results. Xylem believes that improving wastewater transport, dewatering, gas, software & services and analytics business will bolster its revenues in the quarters ahead. Moreover, stronger residential, commercial and industrial applications businesses would likely strengthen revenues going forward. Moreover, Xylem noted that addition of Pure Technologies and EmNet will enhance its competency. Profitability in the upcoming quarters is anticipated to improve on the back of stronger top-line growth and ongoing productivity initiatives. Increased free cash flow generation will likely be spent over dividend payouts, new capital-expenditure programs and debt repayment. Over the last 60 days, Zacks Consensus Estimate for the stock has moved north for both 2018 and 2019.”
A number of other analysts also recently issued reports on XYL. BMO Capital Markets reiterated a buy rating and issued a $86.00 price objective on shares of Xylem in a report on Friday, February 2nd. Canaccord Genuity reiterated a hold rating and issued a $65.00 price objective on shares of Xylem in a report on Monday, December 11th. Boenning Scattergood reiterated a buy rating on shares of Xylem in a report on Friday, December 15th. Seaport Global Securities reiterated a buy rating and issued a $83.00 price objective on shares of Xylem in a report on Friday, February 2nd. Finally, ValuEngine upgraded shares of Xylem from a hold rating to a buy rating in a report on Thursday, March 1st. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $74.00.
Shares of XYL stock opened at $75.40 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.41 and a current ratio of 1.88. The company has a market cap of $13,563.93, a price-to-earnings ratio of 31.55, a P/E/G ratio of 1.45 and a beta of 1.10. Xylem has a 52 week low of $48.81 and a 52 week high of $79.83.
Xylem (NYSE:XYL) last announced its earnings results on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, hitting the consensus estimate of $0.76. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. Xylem had a net margin of 7.03% and a return on equity of 17.95%. The business’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted $0.66 EPS. analysts forecast that Xylem will post 2.92 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, March 15th. Investors of record on Thursday, February 15th were paid a $0.21 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This is a boost from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 annualized dividend and a dividend yield of 1.11%. Xylem’s dividend payout ratio (DPR) is currently 35.00%.
In related news, Director Curtis J. Crawford sold 7,948 shares of the firm’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $71.77, for a total value of $570,427.96. Following the completion of the transaction, the director now directly owns 55,245 shares of the company’s stock, valued at $3,964,933.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Tomas Brannemo sold 1,151 shares of the firm’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $76.41, for a total transaction of $87,947.91. The disclosure for this sale can be found here. Insiders sold 21,105 shares of company stock valued at $1,540,907 over the last three months. 0.75% of the stock is owned by company insiders.
Several large investors have recently added to or reduced their stakes in XYL. Greenleaf Trust boosted its position in Xylem by 97.4% during the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock worth $102,000 after purchasing an additional 735 shares during the period. Invictus RG bought a new position in Xylem during the third quarter worth $104,000. Hanson & Doremus Investment Management bought a new position in Xylem during the fourth quarter worth $126,000. UMB Bank N A MO bought a new position in Xylem during the fourth quarter worth $205,000. Finally, Close Asset Management Ltd bought a new position in Xylem during the fourth quarter worth $205,000. 86.03% of the stock is owned by institutional investors and hedge funds.
WARNING: “Xylem (XYL) Upgraded by Zacks Investment Research to Buy” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/08/xylem-xyl-upgraded-by-zacks-investment-research-to-buy.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Get a free copy of the Zacks research report on Xylem (XYL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.